Monolaurin - Hennepin Life Sciences

Drug Profile

Monolaurin - Hennepin Life Sciences

Alternative Names: AU1; Glycerol monolaurate - Hennepin Life Sciences; GML Gel

Latest Information Update: 03 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hennepin Life Sciences
  • Class Anti-inflammatories; Antipruritics; Esters; Glycerides; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Urinary tract infections

Most Recent Events

  • 03 Aug 2017 Chemical structure information added
  • 05 Jun 2017 Preclinical trials in Urinary tract infections in USA (Topical), before June 2017
  • 05 Jun 2017 Pharmacodynamics data from a preclinical trials in Urinary tract infections released by Hennepin Life Sciences
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top